Alcon ALC
NYSE ALC
$66.03 -0.52 (-0.78%)
As of: Sep 11, 2026 · 3:59 PM EDT

Alcon (ALC) Cash from Financing Activities (2009 - 2026)

Alcon (ALC) posted Cash from Financing Activities of -$510.0 million for Q2 2026, down 283.46% on a QoQ basis from -$133.0 million in Q1 2026, and down 33.16% year-over-year from -$763.0 million in Q2 2025.

Analysis

Alcon (ALC) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Alcon has reported Cash from Financing Activities for 11 years, with the latest figure at -$510.0 million in Q2 2026.

  • On a quarterly basis, Cash from Financing Activities fell 33.16% year-over-year to -$510.0 million in Q2 2026; TTM through Jun 2026 was -$1.3 billion, a 100.78% decrease from a year earlier, with the FY2025 full-year figure at -$1.1 billion, down 247.52% from the prior year.
  • Cash from Financing Activities was -$510.0 million for Q2 2026 at Alcon, down from -$133.0 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $281.0 million in Q4 2022, with the low at -$510.0 million in Q2 2026.
  • Average Cash from Financing Activities over 5 years is -$129.8 million, with a median of -$89.0 million recorded in 2022.
  • The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities soared 951.52% in 2022, then tumbled 8150.0% in 2025.
  • Over 5 years, Cash from Financing Activities stood at $281.0 million in 2022, then sank by 119.57% to -$55.0 million in 2023, then surged by 92.73% to -$4.0 million in 2024, then sank by 8150.0% to -$330.0 million in 2025, then slumped by 54.55% to -$510.0 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$510.0 million (Q2 2026), -$133.0 million (Q1 2026), and -$330.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn -3.52 Bn
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn -287.90 Mn
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn -343.00 Mn
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn -95.00 Mn
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn -410.00 Mn
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn -300,000.00
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn -510.00 Mn
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn -607.30 Mn
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn -213.50 Mn
10 Zimmer Biomet Holdings 18.00 Bn 17.59 Bn 1.54 Bn -271.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -510.00 Mn
Mar 31, 2026 -133.00 Mn
Dec 31, 2025 -330.00 Mn
Sep 30, 2025 -310.00 Mn
Jun 30, 2025 -383.00 Mn
Dec 31, 2024 -4.00 Mn
Sep 30, 2024 -81.00 Mn
Jun 30, 2024 -171.00 Mn
Mar 31, 2024 -66.00 Mn
Dec 31, 2023 -55.00 Mn
Sep 30, 2023 10.00 Mn
Jun 30, 2023 -145.00 Mn
Mar 31, 2023 -21.00 Mn
Dec 31, 2022 281.00 Mn
Sep 30, 2022 -12.00 Mn
Jun 30, 2022 -188.00 Mn
Mar 31, 2022 -89.00 Mn
Dec 31, 2021 -33.00 Mn
Sep 30, 2021 -14.00 Mn
Jun 30, 2021 -73.00 Mn